|
If LSE is not being left stranded in the current round of exchange consolidation, it needs a Plan B. A merger with Nasdaq OMX looks the best option. The chances of the TMX deal surviving in its current form look slim. TMX has rejected a rival offer from Canadian consortium Maple, but Maple could find ways to address TMX's concerns over leverage and competition, or it could go hostile. Meanwhile, LSE's offer still needs government and regulatory approval.
But if the TMX deal falls through, the LSE will be in a strategic bind. Its share of domestic equities trading has slumped to around 50% from a virtual monopoly a few years ago. It needs to gain scale and cut costs, particularly if a planned merger between rivals Deutsche Börse and NYSE Euronext gets regulatory approval. The Deutsche Börse/NYSE tie-up might yield some regulatory-related asset sales, the crown jewel being derivatives business, Liffe. The LSE could hold out for a takeover bid; the Singapore Exchange was rebuffed from acquiring
A merger with similarly-sized Nasdaq, however, could make sense. The
Full article (FN subscription needed)